Applications of the repeatability of quantitative imaging biomarkers: A review of statistical analysis of repeat data sets

Translational Oncology

Volumn 2, Issue 4, 2009, Pages 231-235

  Barnhart, Huiman X ^a   Barboriak, Daniel P ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ARTICLE; CANCER DIAGNOSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; IMAGE ANALYSIS; MOLECULAR IMAGING; PARAMETER; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; TEST RETEST RELIABILITY; VALIDATION PROCESS;

EID: 77953421826     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.09268     Document Type: Article

References (18)

1. Smith JJ, Sorensen AG, and Thrall JH (2003). Biomarkers in imaging: realizing radiology's future. Radiology 227, 633-638.
2. O'Connor JP, Jackson A, Parker GJ, and Jayson GC (2007). DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96, 189-195.
3. Zhao M, Pipe JG, Bonnett J, and Evelhoch JL (1996). Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73, 61-64.
4. Schuster DP (2007). The opportunities and challenges of developing imaging biomarkers to study lung function and disease. Am J Respir Crit Care Med 176, 224-230.
5. Sorensen AG (2006). Magnetic resonance as a cancer imaging biomarker. J Clin Oncol 24, 3274-3281.
6. Willmann JK, van Bruggen N, Dinkelborg LM, and Gambhir SS (2008). Molecular imaging in drug development. Nat Rev Drug Discov 7, 591-607.
7. Murphy PS, McCarthy TJ, and Dzik-Jurasz AS (2008). The role of clinical imaging in oncological drug development. Br J Radiol 81, 685-692.
8. Armato SG III, Meyer CR, McNitt-Gray MF, McLennan G, Reeves AP, Croft BY, and Clarke LP (2008). The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software. Clin Pharmacol Ther 84, 448-456.
9. McLennan G, Clarke L, and Hohl RJ (2008). Imaging as a biomarker for therapy response: cancer as a prototype for the creation of research resources. Clin Pharmacol Ther 84, 433-436.
10. Halligan S (2002). Reproducibility, repeatability, correlation and measurement error. Br J Radiol 75, 193-194.
11. Bland JM and Altman DG (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307-310.
12. Barnhart HX, Haber MJ, and Lin LI (2007). An overview on assessing agreement with continuous measurements. J Biopharm Stat 17, 529-569.
13. 1H MR spectroscopy for human brain tumors. Korean J Radiol 7, 156-161.
14. 18FDG PET scanning in oncology. Br J Cancer 98, 1597-1601.
15. Goh V, Halligan S, and Bartram C (2007). Quantitative tumor perfusion assessment with multidetector CT: are measurements from two commercial software packages interchangeable? Radiology 242, 777-782.
16. 15O-labeled water positron emission tomography: a comparison study. J Comput Assist Tomogr 33, 460-465.
17. Chow S-C, Shao J, and Wang H (2008). Sample Size Calculations in Clinical Research. Boca Raton, FL: Chapman & Hall/CRC.
18. Metz CE (2006). Receiver operating characteristic analysis: a tool for the quantitative evaluation of observer performance and imaging systems. J Am Coll Radiol 3, 413-422.